TotalMarketCap

NovaBridge Biosciences

NBPNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$104.767 M

$0.91 -10.10%

Close of 6 Nov 2026

As of 6 Nov 2026, NovaBridge Biosciences (NBP) has a market capitalization of $104.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$46.3M

Loss-making

Shares outstanding

265,377,891

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #285OrganogenesisORGO$107.9M
  2. #286Anixa BiosciencesANIX$105.0M
  3. #287NovaBridge BiosciencesNBP$104.8M
  4. #288TuHURA BiosciencesHURA$103.9M
  5. #289EquilliumEQ$103.8M

What if NovaBridge Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$244,725.77

Per share 269,522× higher

Bitcoin $1.53T

$13,241.69

Per share 14,583× higher

Apple $5.02T

$43,471.22

Per share 47,876× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for NovaBridge Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.